Atlas Trials

Exploratory Study of Norepinephrine to Prevent Radiodermatitis in Breast Cancer Patients

Clinical trial NCT01263366 · TERMINATED

Trial details

NCT number
NCT01263366
Sponsor
ProCertus BioPharm, Inc
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Radiodermatitis
Start date
2011-01-01
Primary completion
2013-04-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.